Literature DB >> 3881322

D-penicillamine for primary biliary cirrhosis.

O F James.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3881322      PMCID： PMC1432437          DOI： 10.1136/gut.26.2.109

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  16 in total

1.  Effect of D-penicillamine on copper retention in patients with primary billiary cirrhosis.

Authors:  T B Deering; E R Dickson; C R Fleming; M G Geall; J T McCall; A H Baggenstoss
Journal:  Gastroenterology       Date:  1977-06       Impact factor: 22.682

2.  The presentation and diagnosis of 100 patients with primary biliary cirrhosis.

Authors:  S Sherlock; P J Scheuer
Journal:  N Engl J Med       Date:  1973-09-27       Impact factor: 91.245

3.  Copper and primary biliary cirrhosis.

Authors:  C R Fleming; E R Dickson; A H Baggenstoss; J T McCall
Journal:  Gastroenterology       Date:  1974-12       Impact factor: 22.682

4.  A defect in the intramolecular and intermolecular cross-linking of collagen caused by penicillamine. II. Functional groups involved in the interaction process.

Authors:  K Deshmukh; M E Nimni
Journal:  J Biol Chem       Date:  1969-04-10       Impact factor: 5.157

5.  Circulating immune complexes and complement activation in primary biliary cirrhosis.

Authors:  J R Wands; J L Dienstag; A K Bhan; E R Feller; K J Isselbacher
Journal:  N Engl J Med       Date:  1978-02-02       Impact factor: 91.245

6.  D-penicillamine treatment improves survival in primary biliary cirrhosis.

Authors:  O Epstein; S Jain; R G Lee; D G Cook; A M Boss; P J Scheuer; S Sherlock
Journal:  Lancet       Date:  1981-06-13       Impact factor: 79.321

7.  Primary biliary cirrhosis--a revised clinical spectrum.

Authors:  O James; A F Macklon; A J Watson
Journal:  Lancet       Date:  1981-06-13       Impact factor: 79.321

8.  Reduction of immune complexes and immunoglobulins induced by D-penicillamine in primary biliary cirrhosis.

Authors:  O Epstein; D De Villiers; S Jain; B J Potter; H C Thomas; S Sherlock
Journal:  N Engl J Med       Date:  1979-02-08       Impact factor: 91.245

9.  Is copper hepatotoxic in primary biliary cirrhosis?

Authors:  O Epstein; B Arborgh; M Sagiv; R Wroblewski; P J Scheuer; S Sherlock
Journal:  J Clin Pathol       Date:  1981-10       Impact factor: 3.411

10.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1977-01       Impact factor: 7.640
View more
  5 in total

Review 1.  Primary biliary cirrhosis.

Authors:  J Neuberger; M Lombard; R Galbraith
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

Review 2.  Treatment in primary biliary cirrhosis.

Authors:  N D Finlayson
Journal:  Br Med J (Clin Res Ed)       Date:  1987-10-10

Review 3.  [Primary biliary liver cirrhosis and overlap syndrome. Diagnosis and therapy].

Authors:  C P Strassburg; M P Manns
Journal:  Internist (Berl)       Date:  2004-01       Impact factor: 0.743

4.  Evaluation of the Chinese Medicinal Herb, Graptopetalum paraguayense, as a Therapeutic Treatment for Liver Damage in Rat Models.

Authors:  Li-Jen Su; Chih-Hsueh Yang; Shiu-Feng Huang; Ya-Ling Yuo; Hui-Chu Hsieh; Tzu-Ling Tseng; Chang-Han Chen; Shih-Lan Hsu; Chi-Ying F Huang
Journal:  Evid Based Complement Alternat Med       Date:  2012-07-02       Impact factor: 2.629

Review 5.  Skin Manifestations Associated with Autoimmune Liver Diseases: a Systematic Review.

Authors:  Benedetta Terziroli Beretta-Piccoli; Pietro Invernizzi; M Eric Gershwin; Carlo Mainetti
Journal:  Clin Rev Allergy Immunol       Date:  2017-12       Impact factor: 10.817
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.